Microvessels support engraftment and functionality of human islets and hESC-derived pancreatic progenitors in diabetes models

Islet transplantation is a promising treatment for type 1 diabetes (T1D), yet the low donor pool, poor islet engraftment, and life-long immunosuppression prevent it from becoming the standard of care. Human embryonic stem cell (hESC)-derived pancreatic cells could eliminate donor shortages, but inte...

Full description

Saved in:
Bibliographic Details
Published inCell stem cell Vol. 28; no. 11; pp. 1936 - 1949.e8
Main Authors Aghazadeh, Yasaman, Poon, Frankie, Sarangi, Farida, Wong, Frances T.M., Khan, Safwat T., Sun, Xuetao, Hatkar, Rupal, Cox, Brian J., Nunes, Sara S., Nostro, M. Cristina
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 04.11.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Islet transplantation is a promising treatment for type 1 diabetes (T1D), yet the low donor pool, poor islet engraftment, and life-long immunosuppression prevent it from becoming the standard of care. Human embryonic stem cell (hESC)-derived pancreatic cells could eliminate donor shortages, but interventions to improve graft survival are needed. Here, we enhanced subcutaneous engraftment by employing a unique vascularization strategy based on ready-made microvessels (MVs) isolated from the adipose tissue. This resulted in improved cell survival and effective glucose response of both human islets and hESC-derived pancreatic cells, which ameliorated preexisting diabetes in three mouse models of T1D. [Display omitted] •Microvessels support engraftment of pancreatic cells in the subcutaneous site•Transplantation of microvessels with pancreatic cells accelerates diabetes reversal•Microvessels enable diabetes reversal with a subtherapeutic dose of human islets•Microvessels replenish the intraislet vasculature of the transplanted human islets Aghazadeh et al. show that transplantation of adipose-derived microvessels in the subcutaneous space supports early connection to the host vasculature, promoting engraftment and function of either hESC-derived pancreatic progenitors or human islets. This strategy resulted in improved graft survival and effective glucose response, leading to accelerated reversal of diabetes.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1934-5909
1875-9777
DOI:10.1016/j.stem.2021.08.001